Iwayama Kuninori, Hiura Kazuya, Ohtaki Ko-Ichi
Department of Pharmacotherapy and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.
Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.
Inflamm Intest Dis. 2024 Jul 25;9(1):210-219. doi: 10.1159/000540558. eCollection 2024 Jan-Dec.
In pharmacotherapy for inflammatory bowel disease (IBD), good medication adherence is necessary to control the condition. However, some patients show poor adherence. Pharmacists need to provide appropriate medication guidance to improve medication adherence. Community pharmacists often have to provide medication guidance in case of insufficient patient information because of varying affiliations. Therefore, to help improve medication adherence in patients with IBD and establish cooperation between community and hospital pharmacies, we investigated the awareness of IBD among pharmacists and the actual status of pharmacist-led medication guidance for patients with IBD.
This study comprised a knowledge test for IBD and a survey of medication guidance for IBD in the form of questionnaires, which were administered to pharmacists using web forms.
Community pharmacy affiliation ( < 0.01) and having no experience in medication guidance for IBD ( < 0.01) contributed to low scores in the IBD knowledge test. There was a difference in the correct answer rate for interactions or screening tests prior to medication administration between community and hospital pharmacists. Medication guidance consultations involving residual drug adjustment ( < 0.01), confirmation of symptoms ( < 0.01), prescription from other hospitals ( = 0.04), therapeutic effects ( = 0.04), and confirmation of medication adherence were more common among community pharmacists than among hospital pharmacists. Cooperation between community and hospital pharmacies was most commonly achieved through tracing reports or personal medication handbooks.
Improving pharmacists' awareness of IBD and sharing information are important to facilitate cooperation between community and hospital pharmacists to improve medication adherence.
在炎症性肠病（IBD）的药物治疗中，良好的药物依从性对于控制病情至关重要。然而，一些患者的依从性较差。药剂师需要提供适当的用药指导以提高药物依从性。由于所属机构不同，社区药剂师在患者信息不足的情况下往往需要提供用药指导。因此，为了帮助提高IBD患者的药物依从性并建立社区药房与医院药房之间的合作，我们调查了药剂师对IBD的认知情况以及药剂师为IBD患者提供用药指导的实际状况。
本研究包括一项关于IBD的知识测试以及以问卷形式进行的IBD用药指导调查，通过网络表单向药剂师发放。
社区药房所属机构（<0.01）以及没有IBD用药指导经验（<0.01）导致IBD知识测试得分较低。社区药剂师和医院药剂师在用药前相互作用或筛查测试的正确回答率方面存在差异。涉及剩余药物调整（<0.01）、症状确认（<0.01）、其他医院处方（=0.04）、治疗效果（=0.04）以及用药依从性确认的用药指导咨询在社区药剂师中比在医院药剂师中更为常见。社区药房与医院药房之间的合作最常通过追踪报告或个人用药手册来实现。
提高药剂师对IBD的认知并共享信息对于促进社区药剂师与医院药剂师之间的合作以提高药物依从性很重要。
